Adverum Biotechnologies Inc share price logo

Adverum Biotechnologies Inc Share Price

NASDAQ: ADVM

$4.38

+0.12

(+2.70%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 8 Dec 2025

Adverum Biotechnologies Inc Stock Performance

as on December 9, 2025 at 7:59 am IST

  • Day's Low

    Day's High

    $4.24
    $4.36
    downward going graph

    3.20%

    Downside

    -0.46%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.78
    $5.75
    downward going graph

    59.36%

    Downside

    31.28%

    Upside

    downward going graph

Adverum Biotechnologies Inc share price movements today

Previous Close
$4.26
Open
$4.25
Volume
1.2M
Day's Low - High
$4.24 - $4.36
52 Week Low - High
$1.78 - $5.75

Adverum Biotechnologies Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Adverum Biotechnologies Inc Stock Fundamentals & Key Indicators

Check Adverum Biotechnologies Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Adverum Biotechnologies Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adverum Biotechnologies Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Adverum Biotechnologies Inc image
Adverum Biotechnologies Inc
BUY$-NANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$35.0B358.32%-16.34-210.54%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.3B124.84%136.858.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.4B105.93%28.6632.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.5B60.41%18.3831.41%

Analyst Recommendation on Adverum Biotechnologies Inc Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Adverum Biotechnologies Inc. Average target price of $4.9

Adverum Biotechnologies Inc Share Price Target

Get share price movements and forecasts by analysts on Adverum Biotechnologies Inc.

What analysts predicted

10.61%UPSIDE

Target Price

$4.9

Current Price

$4.38

Analyzed by

13 Analysts

Target

$4.90

Adverum Biotechnologies Inc target price $4.9, a slight upside of 10.61% compared to current price of $4.38. According to 13 analysts rating.

Adverum Biotechnologies Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-3
-
-
1
-
-3
-
-
Gross Profit
-7
-1
-4
0
0
1
-
0
0
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-31
-32
-23
-27
-30
-27
-60
-47
-49
-47
Net Profit Margin
0.00%
0.00%
658.72%
0.00%
0.00%
-2713.40%
0.00%
1306.08%
0.00%
0.00%

Adverum Biotechnologies Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
2
1
1
1
0
7
7
3
3
1
Gross Profit
2
1
0
1
0
-4
7
-6
3
1
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-47
-113
-56
-72
-64
-117
-145
-154
-122
-130
Net Profit Margin
-2046.27%
-7817.66%
-3036.61%
-4505.40%
-25794.40%
-1566.76%
-1940.53%
-4292.67%
-3392.11%
-13092.70%

Global Institutional Holdings in Adverum Biotechnologies Inc

Funds
Holdings
BML Capital Management LLC
14.57%
TCG Crossover Management, LLC
8.56%
Principia Wealth Advisory, LLC
8.09%
Vanguard Group Inc
4.21%
Renaissance Technologies Corp
2.72%
See all

Adverum Biotechnologies Inc News & Key Events

  • img

    Today's Timeline - 24 October

    Fri, 11:06 PM

    -

    Eli Lilly enters definitive agreement to acquire Adverum Biotechnologies, launching a tender offer for all outstanding shares.

Insights on Adverum Biotechnologies Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ADVM stock has moved up by 38.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 161.7% return, outperforming this stock by 188.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 951.8% return, outperforming this stock by 981.5%

About Adverum Biotechnologies Inc

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. It discovers and develops gene therapy product candidates that provide durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections. Ixo-vec is being developed for the treatment of patients with wet age-related macular degeneration (wet AMD). Its other partnered programs include BGTF-027 (AAV.7m8-L-opsin), a gene therapy product candidate designed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy (BCM) via a single IVT injection.
OrganisationAdverum Biotechnologies Inc
E-voting on sharesClick here to vote

FAQs

What is Adverum Biotechnologies Inc share price today?

Adverum Biotechnologies Inc share price today is $4.38 as on at the close of the market. Adverum Biotechnologies Inc share today touched a day high of $4.36 and a low of $4.24.

What is the 52 week high and 52 week low for Adverum Biotechnologies Inc share?

Adverum Biotechnologies Inc share touched a 52 week high of $5.75 on and a 52 week low of $1.78 on . Adverum Biotechnologies Inc stock price today i.e. is closed at $4.38,which is 23.83% down from its 52 week high and 146.07% up from its 52 week low.

How to invest in Adverum Biotechnologies Inc Stock (ADVM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Adverum Biotechnologies Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adverum Biotechnologies Inc Shares that will get you 0.3425 shares as per Adverum Biotechnologies Inc share price of $4.38 per share as on December 9, 2025 at 2:29 am IST.

What is the minimum amount required to buy Adverum Biotechnologies Inc Stock (ADVM) from India?

Indian investors can start investing in Adverum Biotechnologies Inc (ADVM) shares with as little as ₹92.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Adverum Biotechnologies Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Adverum Biotechnologies Inc share’s latest price of $4.38 as on December 9, 2025 at 2:29 am IST, you will get 2.2831 shares of Adverum Biotechnologies Inc. Learn more about fractional shares .